Cardiff Lexington Announces Uplisting to OTCQB Venture Market
Cardiff Lexington Corporation (OTCQB:CDIX) has successfully uplisted to the OTCQB Venture Market, effective May 15, 2025, while maintaining its "CDIX" ticker symbol. The uplisting follows a thorough verification process to ensure the company meets OTCQB listing requirements.
CEO Alex Cunningham highlighted this achievement as a significant milestone, emphasizing the company's commitment to transparency and shareholder value. The company reports being on track for a record 2025 and has made progress in streamlining its capital structure. The OTCQB listing, operated by OTC Markets Group and recognized by the SEC, is expected to enhance Cardiff Lexington's visibility with investors and support the expansion of its global shareholder base.
Cardiff Lexington Corporation (OTCQB:CDIX) è stata promossa con successo al OTCQB Venture Market, a partire dal 15 maggio 2025, mantenendo il simbolo di borsa "CDIX". La promozione è avvenuta dopo un accurato processo di verifica per garantire che l'azienda soddisfi i requisiti di quotazione OTCQB.
Il CEO Alex Cunningham ha sottolineato questo traguardo come un momento importante, evidenziando l'impegno dell'azienda verso la trasparenza e il valore per gli azionisti. L'azienda segnala di essere in linea per un 2025 record e ha compiuto progressi nella semplificazione della struttura del capitale. La quotazione OTCQB, gestita da OTC Markets Group e riconosciuta dalla SEC, dovrebbe aumentare la visibilità di Cardiff Lexington presso gli investitori e supportare l'espansione della sua base globale di azionisti.
Cardiff Lexington Corporation (OTCQB:CDIX) ha logrado ascender exitosamente al OTCQB Venture Market, efectivo desde el 15 de mayo de 2025, manteniendo su símbolo bursátil "CDIX". La subida se realizó tras un exhaustivo proceso de verificación para asegurar que la empresa cumple con los requisitos de listado OTCQB.
El CEO Alex Cunningham destacó este logro como un hito significativo, enfatizando el compromiso de la compañía con la transparencia y el valor para los accionistas. La empresa informa estar encaminada para un 2025 récord y ha avanzado en la simplificación de su estructura de capital. La cotización OTCQB, operada por OTC Markets Group y reconocida por la SEC, se espera que aumente la visibilidad de Cardiff Lexington frente a los inversores y apoye la expansión de su base global de accionistas.
Cardiff Lexington Corporation (OTCQB:CDIX)는 2025년 5월 15일부터 OTCQB 벤처 마켓으로 성공적으로 상향 이전했으며, "CDIX" 티커 심볼을 유지하고 있습니다. 이번 상향 이전은 회사가 OTCQB 상장 요건을 충족하는지 철저히 검증하는 과정을 거쳤습니다.
CEO 알렉스 커닝햄은 이 성과를 중요한 이정표로 강조하며, 회사의 투명성과 주주 가치를 위한 노력을 강조했습니다. 회사는 2025년 기록적인 성과를 기대하고 있으며 자본 구조 간소화에도 진전을 이루고 있습니다. OTCQB 상장은 OTC 마켓 그룹이 운영하며 SEC가 인정하는 시장으로, Cardiff Lexington의 투자자 가시성을 높이고 글로벌 주주 기반 확장을 지원할 것으로 예상됩니다.
Cardiff Lexington Corporation (OTCQB:CDIX) a réussi à être promue sur le OTCQB Venture Market, effective à partir du 15 mai 2025, tout en conservant son symbole boursier "CDIX". Cette promotion fait suite à un processus rigoureux de vérification afin de garantir que l'entreprise respecte les critères de cotation OTCQB.
Le PDG Alex Cunningham a souligné cette réussite comme une étape importante, mettant en avant l'engagement de la société envers la transparence et la création de valeur pour les actionnaires. L'entreprise indique être en bonne voie pour une année 2025 record et a progressé dans la simplification de sa structure de capital. La cotation OTCQB, opérée par OTC Markets Group et reconnue par la SEC, devrait accroître la visibilité de Cardiff Lexington auprès des investisseurs et soutenir l'expansion de sa base mondiale d'actionnaires.
Cardiff Lexington Corporation (OTCQB:CDIX) wurde zum 15. Mai 2025 erfolgreich in den OTCQB Venture Market hochgestuft und behält dabei das Tickersymbol "CDIX" bei. Die Hochstufung erfolgte nach einem gründlichen Prüfverfahren, um sicherzustellen, dass das Unternehmen die Anforderungen für die OTCQB-Notierung erfüllt.
CEO Alex Cunningham bezeichnete diesen Erfolg als wichtigen Meilenstein und betonte das Engagement des Unternehmens für Transparenz und den Wert für die Aktionäre. Das Unternehmen berichtet, auf dem besten Weg für ein Rekordjahr 2025 zu sein und Fortschritte bei der Straffung seiner Kapitalstruktur gemacht zu haben. Die OTCQB-Notierung, betrieben von der OTC Markets Group und von der SEC anerkannt, soll die Sichtbarkeit von Cardiff Lexington bei Investoren erhöhen und die Erweiterung der globalen Aktionärsbasis unterstützen.
- Successful uplisting to OTCQB Venture Market, potentially increasing investor visibility and credibility
- Company reports being on track for record performance in 2025
- Management reports significant streamlining of capital structure
- Enhanced potential for expanding global shareholder base
- None.
LEXINGTON, KY / ACCESS Newswire / May 20, 2025 / Cardiff Lexington Corporation (OTCQB:CDIX) today announced that the Company's stock has successfully uplisted and commenced trading on the OTCQB Venture Market (the "OTCQB"), effective Thursday, May 15, 2025. The Company will continue to trade under the ticker symbol "CDIX." This uplisting was achieved following a successful application and approval process to verify that Cardiff Lexington meets OTCQB listing qualifications.
Alex Cunningham, Chief Executive Officer of Cardiff Lexington, commented, "Uplisting to the OTCQB Venture Market represents a significant milestone for our Company and reflects our commitment to transparency, growth, and delivering long-term value to our shareholders. We have made considerable progress expanding our business and putting Cardiff Lexington on track for a record 2025 while also significantly streamlining our capital structure. This achievement enhances our visibility with investors and supports our continued momentum as we move through 2025 and beyond."
The OTCQB, operated by OTC Markets Group and recognized by the U.S. Securities and Exchange Commission (SEC) as a reputable public market for early stage and developing U.S. and internal companies, offers investors essential data to evaluate, value, and trade securities. Cardiff Lexington's inclusion in the OTC Markets Group is expected to support the expansion and diversification of its global shareholder base.
-----
About Cardiff Lexington Corporation:
Cardiff Lexington Corporation is a unique targeted healthcare holding company focused on locating, acquiring, and building middle market, niche companies, primarily in Orthopedics, Spine Care, and Pain Management. Fundamental to the Cardiff Lexington strategy is the service-based partnership culture which emphasizes core values, teamwork, accountability, and performance.
A substantial majority of the Company's revenue is derived from Nova Ortho and Spine, LLC, which operates a group of regional primary specialty and ancillary care facilities throughout Florida and Georgia that provide traumatic injury victims with a full range of diagnostic and surgical services, primary care evaluations, interventional pain management, and specialty consultation services.
Cardiff Lexington trades on the OTCQB Venture Market for early stage and developing U.S. and international companies. Companies are current in their reporting and undergo an annual verification and management certification process. Investors can find Real-Time quotes and market information for the company on www.otcmarkets.com.
For more information on Cardiff Lexington Corporation, you may access the company's website at https://cardifflexington.com/
FORWARD-LOOKING STATEMENT: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. These risks include the failure to meet schedule or performance requirements of the Company's business, the Company's liquidity position, the Company's ability to obtain new business, the emergence of competitors with greater financial resources, and the impact of competitive pricing. In the light of these uncertainties the forward-looking events referred to in this release might not occur.
Cardiff Lexington Investor Relations
investorsrelations@cardifflexington.com
(800) 628-2100 ext. 705
or
IMS Investor Relations
cardifflexington@imsinvestorrelations.com
(203) 972-9200
SOURCE: Cardiff Lexington Corporation
View the original press release on ACCESS Newswire
FAQ
What does Cardiff Lexington's (CDIX) uplisting to OTCQB mean for investors?
When did Cardiff Lexington (CDIX) begin trading on the OTCQB Venture Market?
What are the benefits of Cardiff Lexington's OTCQB uplisting?
What is Cardiff Lexington's (CDIX) business outlook for 2025?
